Gurit stock tumbles after UBS downgrade on slowing growth
Source: Investing.com

Gurit shares fell 11% after UBS downgraded the composite-materials maker to Neutral from Buy, despite raising its price target to CHF57. UBS expects 2027 growth to weaken as the wind-materials segment, roughly 55% of sales, faces lower offshore-installation activity, while manufacturing solutions, about 15% of sales, could decline amid volatile customer capex. The bank expects restructuring-driven margin tailwinds to fade, although it raised terminal EBITDA-margin assumptions by 50bps to 10% and remains constructive on medium-term wind and defense opportunities.
Analysis
The relevant setup is not a deteriorating balance sheet but a likely de-rating from peak revision momentum: once restructuring-led operating leverage is exhausted, incremental earnings growth must come from volume and mix. That shifts valuation sensitivity sharply toward order intake and utilization; a modest miss in wind-materials volumes can create disproportionate EBITDA downside because fixed manufacturing costs re-enter the equation. The market is likely to discount this over the next 1-3 months as investors reset the earnings multiple before any reported 2027 weakness appears.
The key second-order signal is the offshore-development pipeline, not near-term turbine headlines. A deferral in final investment decisions, permitting, vessel availability, or grid-connection schedules would flow into Gurit's materials demand with a lag, while customers can reduce inventory before reported installation data turn down. Conversely, subsea-defense demand is strategically attractive but should not receive a full offsetting multiple until management discloses backlog, program duration, customer concentration, and margin conversion; defense opportunities often have longer qualification and revenue-recognition cycles than the market assumes.
Consensus may be too bearish on long-run margin resilience but insufficiently skeptical of the near-term earnings bridge. A transition-year narrative after a large rerating can produce a 20-30% drawdown even if absolute EPS estimates move only mid-single digits, particularly in a relatively less-liquid Swiss small/mid-cap. The thesis is falsified if offshore order visibility improves materially, manufacturing-solutions order intake reaccelerates for two consecutive quarters, or disclosed defense backlog is large enough to cover the anticipated volume gap.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment
Key Decisions for Investors
- Avoid initiating fresh GURN/GUR longs before the next order-intake or guidance update; treat any near-term bounce as a liquidity-driven opportunity to reduce exposure unless management quantifies 2027 defense backlog and margin contribution.
- For holders with access to SIX liquidity, consider a 1-3 month tactical underweight/short GUR against a long HXL basket only after confirming borrow and turnover. The intended payoff is multiple compression from fading revisions rather than a large fundamental EPS collapse; cover if GUR recovers above the post-downgrade high on improved offshore backlog disclosure.
- Use HXL as the cleaner listed watch proxy for aerospace/composite demand rather than assuming Gurit's wind-cycle weakness generalizes across composites. A divergence in HXL aerospace order commentary versus GUR wind-materials intake would support the idiosyncratic short thesis.
- Set an event alert for offshore-wind FID announcements and European grid/permitting decisions over the next 3-6 months. Positive project sanctioning alone is not sufficient to buy GUR; require evidence that supplier ordering is advancing rather than merely that installations are scheduled further out.
More News
- Coupang stock hits 52-week low at $13.37
- Italy scales back defence spending hike in new budget plan
- Nvidia stock hits all-time high of 236.57 USD
- Integra LifeSciences cuts 2026 guidance after flooding impact
- Stifel reiterates Glaukos stock rating on strong Epioxa survey
- Piper Sandler reiterates Neutral rating on AppLovin stock at $325